H18402
Hydroquinonesulfonic acid potassium salt
technical grade
동의어(들):
2,5-Dihydroxybenzenesulfonic acid potassium salt, Potassium 2,5-dihydroxybenzenesulfonate
로그인조직 및 계약 가격 보기
모든 사진(2)
About This Item
Linear Formula:
(HO)2C6H3SO3K
CAS Number:
Molecular Weight:
228.26
Beilstein:
5187027
EC Number:
MDL number:
UNSPSC 코드:
12352100
PubChem Substance ID:
NACRES:
NA.22
추천 제품
신호어
Warning
유해 및 위험 성명서
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
표적 기관
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
개인 보호 장비
dust mask type N95 (US), Eyeshields, Gloves
이미 열람한 고객
Daniela Valeria Tomasino et al.
Polymers, 13(4) (2021-03-07)
Poly(3,4-ethylenedioxythiophene) (PEDOT) plays a key role in the field of electrically conducting materials, despite its poor solubility and processability. Various molecules and polymers carrying sulfonic groups can be used to enhance PEDOT's electrical conductivity. Among all, sulfonated polyarylether sulfone (SPAES)
James E Miles et al.
Acta orthopaedica, 82(5), 622-627 (2011-09-08)
The presence of bone marrow edema in patients with osteoarthritis is associated with pain and disease progression. Management of bone edema with the synthetic prostacyclin iloprost may be complicated by side effects. Calcium dobesilate, a treatment for chronic venous disease
Javier Angulo et al.
European journal of pharmacology, 667(1-3), 153-159 (2011-06-28)
Vascular endothelial growth factor (VEGF) is a key factor in angiogenesis and vascular permeability which is associated with many pathological processes. 2,5-hydroxybenzene sulfonate (DHBS; dobesilate) is a small molecule with anti-angiogenic activity that has been described as an inhibitor of
Christos Haritoglou et al.
Lancet (London, England), 373(9672), 1364-1371 (2009-04-21)
Medical treatment for diabetic retinopathy could have an important role in prevention of complications such as visual loss. We aimed to assess the effect of calcium dobesilate on occurrence of diabetic macular oedema. We undertook a randomised, double-blind, placebo-controlled, multicentre
E Rabe et al.
Phlebology, 26(4), 162-168 (2011-04-12)
To test the efficacy of calcium dobesilate (CaD) in chronic venous insufficiency (CVI). Double-blind, parallel groups, placebo-controlled, multicentre trial in adult patients with symptomatic CVI and pitting oedema. Wearing of compression stockings Class II was admitted. During treatment period of
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.